News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,685 Results
Type
Article (41988)
Company Profile (334)
Press Release (665363)
Section
Business (210217)
Career Advice (2080)
Deals (36589)
Drug Delivery (100)
Drug Development (82906)
Employer Resources (171)
FDA (16496)
Job Trends (15361)
News (355604)
Policy (33841)
Tag
Academia (2577)
Alliances (51224)
Alzheimer's disease (1275)
Approvals (16446)
Artificial intelligence (157)
Bankruptcy (362)
Best Places to Work (11717)
Biotechnology (216)
Breast cancer (191)
Cancer (1395)
Cardiovascular disease (116)
Career advice (1741)
Cell therapy (285)
Clinical research (66270)
Collaboration (496)
Compensation (263)
COVID-19 (2613)
C-suite (110)
Data (1400)
Diabetes (174)
Diagnostics (6256)
Earnings (86579)
Employer resources (149)
Events (112886)
Executive appointments (402)
FDA (17177)
Funding (432)
Gene therapy (206)
GLP-1 (631)
Government (4455)
Healthcare (18878)
Infectious disease (2705)
Inflammatory bowel disease (115)
Interviews (320)
IPO (16618)
Job creations (4052)
Job search strategy (1488)
Layoffs (439)
Legal (8327)
Lung cancer (199)
Lymphoma (100)
Manufacturing (215)
Medical device (13298)
Medtech (13303)
Mergers & acquisitions (20122)
Metabolic disorders (470)
Neuroscience (1606)
NextGen Class of 2024 (6627)
Non-profit (4516)
Northern California (1701)
Obesity (268)
Opinion (208)
Patents (120)
People (58422)
Phase I (20521)
Phase II (29162)
Phase III (21870)
Pipeline (517)
Postmarket research (2652)
Preclinical (8742)
Radiopharmaceuticals (243)
Rare diseases (271)
Real estate (6241)
Regulatory (22518)
Research institute (2359)
Resumes & cover letters (358)
Southern California (1468)
Startups (3715)
United States (15335)
Vaccines (582)
Weight loss (196)
Date
Today (34)
Last 7 days (591)
Last 30 days (2453)
Last 365 days (35769)
2024 (35571)
2023 (40646)
2022 (51809)
2021 (56338)
2020 (54804)
2019 (47416)
2018 (35788)
2017 (33154)
2016 (32673)
2015 (38623)
2014 (32525)
2013 (27640)
2012 (29734)
2011 (30501)
2010 (28507)
Location
Africa (777)
Arizona (202)
Asia (40171)
Australia (6427)
California (3836)
Canada (1455)
China (311)
Colorado (174)
Connecticut (179)
Europe (85566)
Florida (535)
Georgia (135)
Illinois (394)
Indiana (232)
Maryland (634)
Massachusetts (3008)
Michigan (174)
Minnesota (291)
New Jersey (1118)
New York (1086)
North Carolina (760)
Northern California (1701)
Ohio (146)
Pennsylvania (929)
South America (1158)
Southern California (1468)
Texas (557)
Utah (109)
Washington State (406)
707,685 Results for "ligand pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Ligand to Participate in Upcoming May 2024 Investor Conferences
Ligand Pharmaceuticals Incorporated announced that Todd Davis and Tavo Espinoza will participate in the following upcoming investor conferences: Craig-Hallum Institutional Investor Conference.
May 23, 2024
·
2 min read
BioMidwest
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
Ligand Pharmaceuticals Incorporated and Agenus Inc. announced that the companies have entered into a royalty financing agreement to support Agenus’ key development initiatives in the ongoing BOT/BAL clinical development program.
May 7, 2024
·
11 min read
Business
Ligand Reports First Quarter 2024 Financial Results
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three months ended March 31, 2024, and provided an operating forecast and business updates.
May 7, 2024
·
22 min read
Deals
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that effective March 1, 2024, Ligand’s Human Capital Management and Compensation Committee approved the grant of a non-qualified stock option award to purchase 15,100 shares of its common stock to one non-executive employee.
March 4, 2024
·
2 min read
Business
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its collaborator Merck, known as MSD outside the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for CAPVAXIVE.
June 18, 2024
·
4 min read
Business
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Ligand Pharmaceuticals (Nasdaq: LGND) today announced the launch of Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and the appointment of seasoned industry executive Scott Plesha to the role of Chief Executive Officer.
April 3, 2024
·
7 min read
Press Releases
Ligand Hosts 2024 Investor and Analyst Day and Introduces 2025 Guidance
December 11, 2024
·
10 min read
Press Releases
Ligand to Present at Stifel 2024 Healthcare Conference
November 14, 2024
·
2 min read
Business
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Verona Pharma plc has received approval from the U.S. Food and Drug Administration (FDA) for Ohtuvayre™ (ensifentrine).
June 27, 2024
·
6 min read
Business
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
Ligand Pharmaceuticals Incorporated announced it has appointed Richard Baxter to the role of Senior Vice President of Investment Operations, and Karen Reeves, M.D., to Senior Vice President of Clinical Strategy and Investments.
February 16, 2024
·
4 min read
1 of 70,769
Next
